Avatar of NewsDeck

Author

NewsDeck

XRP

- 427 days ago 4 mins
427 days ago
4
Oct
XRP Headed for a Massive Breakout by Q1 2025, Analysts Say 2200% Gain for This Other Token Under $0.08 Is Imminent

Due to an extreme price rally underway, XRP's price could soar by Q1 2025. Simultaneously,

- 429 days ago 3 mins
429 days ago
2
Oct
Bitwise XRP ETF S-1 Form Now Filed With SEC

Bitwise Asset Management has submitted an S-1 registration form to the SEC to launch Bitwise

- 429 days ago 3 mins
429 days ago
2
Oct
Top 5 Most Cheap Altcoins Ready for 2000% Gains in the Next 5 Months

Among those cryptos let us look into the top 5 cheap digital assets: Shiba Inu

- 430 days ago 2 mins
430 days ago
2
Oct
Bitwise Spot XRP ETF Was Proposed With Community Excitement

Bitwise spot XRP ETF has been proposed with Delaware’s Division of Corporations, despite no U.S.

- 435 days ago 3 mins
435 days ago
26
Sep
Best Crypto to Buy Now: BlockDAG’s Partnerships and Potential Amid XRP Price Fluctions and AVAX Upgrades

Learn about BlockDAG's $76.2M presale and strategic soccer club partnerships. Explore the XRP price trajectory

- 436 days ago 3 mins
436 days ago
26
Sep
Shiba Inu & XRP Traders Switching to BlockDAG? Grab Your 50% Extra BDAG Before It’s Too Late!

ead about BlockDAG's upcoming rebrand and its explosive ROI potential, amidst Shiba Inu's price woes

- 439 days ago 5 mins
439 days ago
22
Sep
XRP Holders Hopeful for $1 Amid Ongoing Developments, Ethereum Investor Sentiment Improves, Rexas Finance (RXS) Blows Up in Presale

There are constant transformations witnessed in the crypto markets, especially with some key projects such

- 447 days ago 3 mins
447 days ago
15
Sep
BlockDAG Teams Up with Borussia Dortmund, Eyes on $30 Mark! Challenges Ahead for Aptos and XRP

Discover BlockDAG's exciting collaboration with Borussia Dortmund and what it means for its future. Learn

- 449 days ago 3 mins
449 days ago
12
Sep
Grayscale XRP Trust Is Now Launched for Accredited Investors

Grayscale XRP Trust could eventually evolve into an ETF with regulatory approval, following the path